| scholarly article | Q13442814 |
| P50 | author | Tebeb Gebretsadik | Q90344341 |
| Ayumi K Shintani | Q114294298 | ||
| Annette Oeser | Q124366609 | ||
| Theodore Pincus | Q64689192 | ||
| P2093 | author name string | Tuulikki Sokka | |
| C Michael Stein | |||
| Cecilia P Chung | |||
| Young Hee Rho | |||
| Joseph Solus | |||
| P2860 | cites work | Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor | Q24336391 |
| Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis | Q24568212 | ||
| FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family | Q24630827 | ||
| Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | Q24800930 | ||
| Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index | Q81517338 | ||
| Resistin, an adipokine with potent proinflammatory properties | Q81672242 | ||
| Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans | Q83832861 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Adipocytokines: mediators linking adipose tissue, inflammation and immunity | Q29619393 | ||
| Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis | Q30884235 | ||
| Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD | Q33336612 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin | Q34377294 | ||
| Leptin consumption in the inflamed joints of patients with rheumatoid arthritis | Q35552048 | ||
| Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis | Q35555870 | ||
| Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. | Q35637875 | ||
| Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum | Q35760141 | ||
| Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years | Q35788492 | ||
| Mechanisms of disease: is osteoporosis the obesity of bone? | Q36577405 | ||
| Adiponectin as an anti-inflammatory factor | Q36753830 | ||
| Leptin signaling and obesity: cardiovascular consequences | Q36943073 | ||
| Adipokines as emerging mediators of immune response and inflammation. | Q37014112 | ||
| Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity | Q37077995 | ||
| Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis | Q38293245 | ||
| Induction of leptin resistance through direct interaction of C-reactive protein with leptin | Q38314557 | ||
| Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. | Q38323455 | ||
| Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities | Q42518164 | ||
| Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. | Q46568292 | ||
| The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. | Q51465773 | ||
| Serum leptin in rheumatoid arthritis. | Q51472986 | ||
| Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. | Q53584799 | ||
| How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. | Q53637452 | ||
| Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. | Q54595058 | ||
| A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis | Q58234922 | ||
| Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire | Q71095022 | ||
| Continuous progression of radiological destruction in seropositive rheumatoid arthritis | Q73521049 | ||
| Adipocytokines in synovial fluid | Q79101915 | ||
| Systemic and local regulation of articular cartilage metabolism: Where does leptin fit in the puzzle? | Q79288151 | ||
| Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis ? | Q79356040 | ||
| Relation between body mass index and radiological progression in patients with rheumatoid arthritis | Q79368449 | ||
| Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
| Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity | Q81516516 | ||
| P433 | issue | 7 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1906-1914 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. | |
| P478 | volume | 60 |
| Q36094049 | A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease. |
| Q35857780 | A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article |
| Q34021686 | Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis |
| Q51766923 | Adipokines and inflammation: is it a question of weight? |
| Q37700750 | Adipokines as potential biomarkers in rheumatoid arthritis |
| Q26865268 | Adipokines, metabolic syndrome and rheumatic diseases |
| Q34228799 | Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity |
| Q48331415 | Adiponectin exerts a potent anti-arthritic effect and insulin resistance in collagen-induced arthritic rats. |
| Q58797878 | An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis |
| Q34119529 | Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration |
| Q36528874 | Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis |
| Q89441396 | Association of single nucleotide polymorphisms in resistin gene with rheumatoid arthritis in a Chinese population |
| Q37121668 | Associations of metabolic factors and adipokines with pain in incipient upper extremity soft tissue disorders: a cross-sectional study |
| Q58234801 | Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis |
| Q26864855 | Beyond fat mass: exploring the role of adipokines in rheumatic diseases |
| Q38763702 | Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations |
| Q37869467 | Cardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines. |
| Q52726197 | Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies. |
| Q51135653 | Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis. |
| Q30251936 | Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. |
| Q92104501 | Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis |
| Q43836990 | Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis |
| Q41108607 | Decrease of Markers Related to Bone Erosion in Serum of Patients with Musculoskeletal Disorders after Serial Low-Dose Radon Spa Therapy. |
| Q30839061 | Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort |
| Q28083506 | Early biomarkers of joint damage in rheumatoid and psoriatic arthritis |
| Q34189534 | Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats. |
| Q38209820 | Emerging role of leptin in rheumatoid arthritis |
| Q92542142 | Fat-Produced Adipsin Regulates Inflammatory Arthritis |
| Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
| Q48365860 | Human microbiome, infections, and rheumatic disease |
| Q35089525 | Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis. |
| Q33750548 | Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis |
| Q83233980 | Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis |
| Q37281848 | Inflammation and hypertension in rheumatoid arthritis |
| Q36545914 | Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction |
| Q34104339 | Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis |
| Q34901953 | LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study |
| Q89282110 | Leptin as an obesity marker in rheumatoid arthritis |
| Q33577477 | Leptin in immuno-rheumatological diseases |
| Q64944296 | Leptin is associated with disease activity but not with anthropometric indices in rheumatoid arthritis patients. |
| Q36245922 | Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? |
| Q47401668 | Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms |
| Q94502517 | Metabolic Checkpoints in Rheumatoid Arthritis |
| Q35135460 | NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis |
| Q36993938 | Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro |
| Q89099319 | Obesity Associated With Active, but Preserved Joints in Rheumatoid Arthritis: Results From our National Registry |
| Q38044505 | Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management |
| Q34488394 | Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). |
| Q37801496 | Obesity in rheumatoid arthritis |
| Q38005192 | PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis? |
| Q35065164 | Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage? |
| Q35605424 | Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial |
| Q37358099 | Recent advances in neutralizing the IL-6 pathway in arthritis. |
| Q58134820 | Relationship Between Leptin and Neopterin Levels and Disease Activation Parameters in Patients With Rheumatoid Arthritis |
| Q86313523 | Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression |
| Q51483437 | Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis. |
| Q37385755 | Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases |
| Q36830486 | Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk |
| Q27008359 | Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases |
| Q38380562 | Roles of leptin in bone metabolism and bone diseases |
| Q52872059 | Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. |
| Q37389102 | Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study |
| Q51870089 | Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. |
| Q37690729 | Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort |
| Q40984407 | Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. |
| Q36409526 | Sex differences in assessment of obesity in rheumatoid arthritis |
| Q36693727 | Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid Arthritis |
| Q43836571 | The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis |
| Q36741296 | The effects of adipokines on cartilage and meniscus catabolism |
| Q28284835 | The role of the microbiome in rheumatic diseases |
| Q36148660 | Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis |
| Q35652911 | Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis |
| Q92503476 | Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis |
| Q43749611 | Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients |
| Q82928639 | Visfatin levels and intima-media thicknesses in rheumatic diseases |
| Q37690440 | Visfatin: a potential therapeutic target for rheumatoid arthritis |
| Q37909903 | What's new in our understanding of the role of adipokines in rheumatic diseases? |
Search more.